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Abstract
Purpose of Review Theoretical benefits of real-time MRI guidance over conventional electrophysiology include contemporane-
ous 3D substrate assessment and accurate intra-procedural guidance and evaluation of ablation lesions. We review the unique
challenges inherent to MRI-guided electrophysiology and how to translate the potential benefits in the treatment of cardiac
arrhythmias.
Recent Findings Over the last 5 years, there has been substantial progress, initially in animal models and more recently in clinical
studies, to establish methods and develop workflows within the MR environment that resemble those of conventional electro-
physiology laboratories. Real-time MRI-guided systems have been used to perform electroanatomic mapping and ablation in
patients with atrial flutter, and there is interest in developing the technology to tackle more complex arrhythmias including atrial
fibrillation and ventricular tachycardia.
Summary Mainstream adoption of real-time MRI-guided electrophysiology will require demonstration of clinical benefit and
will be aided by increased availability of devices suitable for use in the MRI environment.
Keywords Magnetic resonance imaging . Electrophysiology . Real-time . Atrial flutter . Ventricular tachycardia . Ablation
Introduction
Electroanatomic mapping (EAM) systems are commonly used
in the conventional electrophysiology laboratory for the guid-
ance of complex arrhythmia procedures. EAM can be used to
generate 3D chamber geometry, enable non-fluoroscopic
localisation of catheters, delineate areas of electrical substrate
and record location of ablation lesions [1]. There are several
limitations however which may account for the modest long-
term success rates of ablation targeting EAM-defined arrhyth-
mia substrate in the setting of complex arrhythmias [2, 3].
Bipolar voltage mapping typically has a limited field of view
and may miss intramural or epicardial substrate, whereas the
use of magnetic resonance imaging (MRI) can identify candi-
date arrhythmogenic substrate in 3D [4]. Voltage amplitude is
also affected by many factors other than the histological char-
acteristics of the underlying tissue including recording elec-
trode size, inter-electrode distance, direction of activation
wavefront, catheter orientation and force of contact [5, 6].
Catheter location in conventional EAM systems is triangulated
using magnetic-based sensing or impedance-based tracking
and displayed on approximate geometries of cardiac chambers
[1]. Visualisation of soft tissue is limited and requires addition-
al imaging equipment in the conventional electrophysiology
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laboratory (e.g. intra-cardiac ultrasound) whilst estimation of
ablation lesion dimensions is dependent on mathematical
modelling of limited biophysical parameters (time, power,
force, change in impedance) rather than a direct visualisation
of transmural, durable lesion formation [7].
Conversely, MRI could offer a number of benefits to the
electrophysiologist including 3D evaluation of chamber ge-
ometry and myocardial structural substrate to complement
functional electrophysiological assessment, accurate tracking
of catheters to improve intra-procedural guidance and assess
ablation lesion formation with soft tissue visualisation [8].
Although centres have integrated anatomical and scar data
from CT or MRI into the navigation system during catheter
ablation [9•, 10], these techniques invariably result in registra-
tion errors of up to 3.5 mm [11]. Additionally, conformational
changes within cardiac chambers as a result of different load-
ing conditions between the time of imaging and intervention
as well as translational changes due to patient movement,
cardiac and respiratory motion could all lead to discrepancies
between structural data and electrical substrate with potential
consequences for the efficacy of catheter ablation [12]. The
mean maximum amplitude of cardiac and respiratory motion,
for example, during EAM has been estimated to be in the
region of 10.2 ± 2.7 mm and 8.8 ± 2.3 mm respectively [13].
Real-time MRI-guided electrophysiology offers a potential
solution to overcome the limitation of image integration as well
as utilise the benefits of MR-based catheter tracking and lesion
assessment that can only be performed inside aMRI scanner [8].
Over the last decade, development of MR-conditional devices
and imaging techniques has led to the application of interven-
tional MRI in the setting of cardiac electrophysiology (Fig. 1)
but a number of challenges have been identified. These include
the recording of high-quality electrograms in an environment
with significant electromagnetic interference, the development
of clinical-grade MR-compatible devices with similar physical
capabilities as their conventional counterparts and establishing
robust tools for real-time lesion assessment [12]. On a practical
level, effective communication is difficult between team mem-
bers in a noisy environment and novel workflows are evolving
to accommodate this hurdle. In this article, we review the prog-
ress made within real-time MRI-guided electrophysiology,
highlighting the unique challenges we have encountered and
their solutions as well as evaluating its application in the treat-
ment of patients with cardiac arrhythmias.
Electrogram Fidelity in the MRI Environment
Accurate recording and characterisation of both surface elec-
trocardiogram (ECG) and intra-cardiac electrograms (EGM)
are an essential component of cardiac electrophysiology pro-
cedures. During catheter ablation of simple arrhythmias such
as atrial flutter, demonstration of bidirectional conduction
block created at the cavo-tricuspid isthmus and proven by
sequential, timed EGM recordings made along the ablation
line during coronary sinus pacing is necessary [14]. For com-
plex arrhythmias such as ventricular tachycardia, substrate-
based mapping techniques rely on the correct identification
of low voltage regions, annotation of abnormal potentials
and robust characterisation of electrogram morphologies [5].
The MRI environment is considered relatively ‘hostile’ for
the rigorous recording of EGMs as there are many sources of
artefact that may distort signals. During MR scanning, RF
pulses are deployed that are coupled with fast-switching mag-
netic gradients which can induce electromagnetic fields
around the subject and create voltage artefacts on both the
surface ECG and intra-cardiac EGMs [15]. A second source
of signal distortion is the magneto-hydrodynamic effect
(MHD). The static magnetic field (B0) can lead to MHD volt-
ages due to the flow of electrically charged blood particles
through the aortic arch in a direction perpendicular to B0.
MHD voltages are superimposed primarily during the S-T
phase of the cardiac cycle (period of peak flow) and can have
a similar frequency spectrum and magnitude to real electro-
gram signals (Fig. 2) [16]. The size ofMHD voltagesmay also
be affected by the heart rate as a different volume of blood
may be ejected from the left ventricle—this may be relevant
during EGM recordings in the context of tachycardia or pac-
ing. A third source of artefacts are time-varying magnetic
fields that provide position-dependent variation in MR field
strength but can lead to induced electric currents in conducting
tissues as well as connecting wires [17].
Fig. 1 Interventional MRI (iCMR) set-up to perform electrophysiology
(EP) procedures. An example set-up for an animal (porcine) study is
shown here. The electrophysiologist can view both electrical and
imaging data on dedicated displays. A foot switch can be used to start/
stop MRI scanning in the same way as during fluoroscopy-guided
procedures. Subject monitoring (Invivo, Gainesville, Florida): four-lead
surface ECG, arterial blood pressure monitoring and oxygen saturation
assessment are available and can be viewed both inside the scanner room
and control room. MR-compatible electrophysiology catheters are
connected to a tracking interface which can transmit tracking data to the
image guidance platform. Radiofrequency (RF) generator, irrigation
pump and EP recording system are located within the control room
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Following the application of a low-pass filter (300 Hz),
high-pass filter (30 Hz), notch filter (60 Hz) and RF filters to
reduce the 64 MHz signal from the MRI scanner, Nazarian
et al. [18] demonstrated the ability to record both atrial and
ventricular potentials in normal canines and healthy patients
including distinguishing small His potentials with good fidel-
ity. Subsequent studies in patients with atrial flutter have
shown that double potentials can be detected along and con-
duction detour around an ablation line [19••, 20••]. An exper-
imental study in an ovine model estimated that the peak-to-
peak amplitude of baseline noise inside the MRI scanner
(without scanning) is 10-fold higher than in a conventional
X-ray fluoroscopy laboratory (0.10 vs 0.01 mV) whilst the
signal-to-noise ratio (SNR) may vary depending on the MRI
sequence used during scanning [21•]. In this study, a low-pass
filter with a cut-off frequency of 120 Hz gave the best quality
EGM signals compared to filter cut-offs at 240 and 500 Hz
[21•]. It remains unclear, however, whether low-amplitude
abnormal potentials such as fractionated EGMs or late poten-
tials with an amplitude < 0.1 mV can be detected robustly
inside a MRI scanner with limited evidence available from
one study [22]. Although a lower value low-pass filter may
give the best quality normal EGM signals, it may risk losing
the fine high-frequency components of abnormal EGMs that
are important in substrate evaluation. Further developments in
signal processing technologies are needed to improve EGM
fidelity, and there has been interest in the application of tech-
niques such as adaptive noise cancellation [23] artefact model-
ling and Bayesian filtering for this purpose [15].
Passive and Active Catheter Tracking
There are two principle methods of intra-procedural guidance
during MRI-guided electrophysiology—active and passive
catheter tracking. Passive catheter tracking enables either
positive or negative contrast visualisation by integration of
susceptibility artefacts generated from ferromagnetic/
paramagnetic materials embedded within a catheter [24] or
using gadolinium or CO2/N2O-filled balloon catheters [25].
Negative contrast techniques may be associated with signal
void artefacts, but these may be discarded through segmenta-
tion of catheter markers—Fig. 3. Typically, during passive
tracking an in-plane resolution of around 1 mm, slice thickness
of 6 mm and temporal resolution of 4 frames/s has been report-
ed [26]. Tip tracking accuracy using gadolinium-filled balloon
catheters has been estimated to be in the region of ± 0.41 mm
with imaging reconstructions displayed at a frame rate of
around 3 frames/s [27]. Recently, application of a positive-
contrast based passive tracking sequence using partial satura-
tion magnetisation preparation has been shown to provide im-
proved simultaneous visualisation of both anatomy as well as
gadolinium-filled catheters [28]. However, susceptibility arte-
facts during passive tracking can make devices with
ferromagnetic/paramagnetic materials appear larger than their
actual size as well as potentially obscure surrounding tissue.
Furthermore, with all passive tracking techniques, if the device
moves out of the imaging plane, the operator is required to
relocate the device which can be time-consuming [29]. It is
also more difficult to track catheters within the expansive 3D
space of cardiac chambers compared to in-plane tracking with-
in the lumen of a vessel (e.g. aorta).
Active catheter tracking is an alternative technique where-
bymicro-coils embeddedwithin the catheter produce a receiv-
er signal to determine location of the device (Fig. 4). An active
tracking sequence consisting of intermittent non-selective ex-
citations combined with spatially encoding gradients enables
measurement of 1D projections in each space dimension and
estimation of the 3D coordinates of the position of the micro-
coils [20••, 30]. Real-time estimates of the position of micro-
coils can be used to estimate catheter tip orientation. This
information can also be used for real-time slice tracking to
A B
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MR scanning with acve tracking sequence No MR scanning MHD voltages during the ST phase
Baseline noise during intra-cardiac EGM recordings Noise reducon following ﬁltering
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Fig. 2 Recording surface ECG and intra-cardiac EGMs inside a MRI
scanner. Significant distortions inside a MRI scanner can occur on both
the surface ECG and during intra-cardiac EGM acquisition due to (1)
time-varying MR gradient fields, (2) RF pulses during MR scanning
that couple to conductive material (a) and (3) magneto-hydrodynamic
(MHD) voltages due to the static magnetic field (b). Noise filtering
technologies are required to improve intra-cardiac EGM fidelity and
reduce baseline noise (c, d)
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automatically maintain the catheter tip in the imaging plane
during navigation [20••]. The precision of active tracking dur-
ing ex vivo technical validation experiments has been estimat-
ed to be in the region of 0.90 ± 0.58 mm along the axis of the
catheter whilst the angular deviation of catheter orientation
from its true direction was 8.50 ± 3.60 [20••]. Active tracking
has been used to perform coronary sinus intubation, activation
mapping and trans-septal left atrial access in swine [31] as
well as to guide cavo-tricuspid isthmus ablation in patients
with atrial flutter [19••, 20••]. Furthermore, active tracking
has also enabled epicardial electroanatomical mapping and
ablation in the porcine left ventricle inside the MRI scanner
[32]. Data comparing a conventional EAM system to EAM
using active tracking inside a MRI scanner are scarce [33] and
are confined to normal porcine hearts. Further head-to-head
comparisons between active tracking and conventional
magnetic-sensor based or impedance-based tracking to guide
catheters to target locations are required to determine the spa-
tial accuracy of the techniques.
Image Guidance Platforms
EAM systems are in widespread use for catheter ablation of
complex arrhythmias. They can facilitate an understanding of
arrhythmia mechanism, permit annotation of single or multi-
ple sites of interest, guide catheter navigation to target ablation
sites and, when properly used, can dramatically reduce fluo-
roscopy times and may reduce procedural times [1]. There has
therefore been interest in the development of graphical inter-
faces to integrate data from real-time imaging into interfaces
that closely mimic those of clinical style EAM systems in
order to drive progress in real-time MRI-guided electrophys-
iology [34]. Several major MRI vendors have developed
graphical solutions to represent electrical data, which enable
real-time imaging with active catheter tracking and workflows
for catheter ablation (Fig. 5). Philips Healthcare has developed
the iSuite system that consists of hardware including a PC and
monitor connected to the MR scanner console. A foot pedal
also allows an operator to directly control the scanner in real-
time from the scanner bore. Additional software capabilities
Fig. 4 Active catheter tracking using a MR-compatible catheter with
gold-tip electrodes and two 2.5-mm solenoid receive coils (a). Using a
dedicated tracking sequence, the X, Y and Z coordinates of the catheter
micro-coils can be determined in 3D space (b) whilst the catheter tip can
be displayed as a red icon in three orthogonal MRI projections to guide a
MR-EP procedure (c)
A B
Fig. 3 Passive catheter tracking with negative contrast using a spoiled gradient echo sequence in coronal orientation with a water-selective excitation
pulse as a catheter is advanced through the aorta (a, b). Arrows show location of electrodes on a hexa-polar catheter
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include the ability to performMRI-guided navigation combin-
ing pre-acquired imaging with real-time data, segmentation
tools for procedural planning, as well as custom modules to
perform MR-based device tracking and support proton-
resonance frequency-based temperature mapping (MR-
thermometry) that may have applications to assess catheter
ablation [8, 20••].
Similarly, Siemens Healthineers have developed their own
interventional MRI platform that allows flexible control of
scan plane orientation and image parameters from a dedicated
PC connected to the scanner console, load and display volu-
metric data onto a custom software as well as perform auto-
matic segmentations of pre-acquired data to ensure rapid im-
age processing [32]. The mapping interface of the software
gives the ability to change the colour or rendering styles of
loaded segmentations and generate activation and voltage
maps based on local activation time or voltage amplitude data
using colour interpolation between mapping points. Active
tracking can be superimposed onto real-time imaging datasets
allowing the system to deliver the features required of a
clinical EAM system as well as having additional capabilities
to exploit the benefits of real-time imaging [32].
TheVurtigo platform, which is compatible with GE systems,
is a real-time visualisation application (open-source) that can
either import EAMs generated conventionally or compose one
using MR-tracked catheters followed by fusion with acquired
MR volumes [29]. A real-time scan control system (RTHawk
research platform) which is based on the Heart Vista Cardiac
operating system (Heart Vista, Los Altos, CA, USA) acts as a
2D viewer and allows acquisition of real-time sequences. The
communication latency between the RTHawk application and
Vurtigo has been estimated to be in the region of 6.3 ± 7.7 ms
[35]. The system has the ability to visualise, compare and over-
lay MRI volumes, real-time imaging planes, catheters and sur-
facemeshes of EAMs. Further developments of features includ-
ing motion correction of mapping data points and improved
signal processing are under evaluation [35].
These systems will require clinical validation to assess the
accuracy of the synchronisation and software algorithms to
evaluate if image guidance platforms can impact on the safety
of electrophysiology procedures through direct monitoring of
structures such as the oesophagus, coronary vessels and peri-
cardium during ablation. Further development and refinement
of image guidance platforms to display real-time assessment of
tissue temperature and predicted tissue necrosis visualise inter-
actions between the catheter tip and endocardial tissue using
interleaved cine imaging during active tracking, and compen-
sation for cardiac and respiratory motion during ablation is an
exciting prospect. The development of automatedmapping sys-
tems integrated with image guidance platforms will be a major
advance in the field, but these systems and associated algo-
rithms will also require robust clinical validation.
Ablation Lesion Assessment
MRI offers superior soft tissue visualisation compared to other
imaging modalities and has been used to assess acute oedema
using T2-weighted imaging and lesion necrosis using late
gadolinium enhancement (LGE) after catheter ablation [36].
T2-weighted imaging however is a poor predictor of chronic
lesion volume [37]. The use of LGE in acute lesion assess-
ment suffers from variable wash-in and wash-out kinetics of
the contrast agent which can lead to the area of necrosis re-
quiring up to an hour to fully enhance [38]. The presence of
acute reversible post-ablation oedema may also manifest as
increased LGE [39]. Recently, in a canine model, the micro-
vascular obstruction region on LGE images acquired 26 min
after contrast administration was found to most accurately
predict chronic lesion volume [40] but acute LGE may still
grossly overestimate chronic lesion volume by a factor of 3.6
[38]. Contrast can generally only be given once during a real-
time MRI-guided procedure and there has therefore been
Fig. 5 Image guidance software platforms for procedure visualisation
have been developed by several MRI vendors that are capable of
displaying 3D volume roadmaps, real-time imaging planes, cardiac
chamber segmentations, electroanatomical maps and actively tracked
catheters. Shown here are example screenshots from the Siemens iCMR
platform (a) during MRI-guided electroanatomical mapping of the left
ventricle in a porcine infarct model and Philips iSuite platform (b) during
MRI-guided catheter ablation of the cavotricuspid isthmus in a patient
with atrial flutter. (Panel b adapted from Chubb et al. JACC Clinical
Electrophysiology 2017: 3; 89–103, with permission from Elsevier)
[20••]. LV left ventricle, IVC inferior vena cava, MPR multi-plane
reconstruction
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interest in the development of intrinsic (non-contrast)-based
methods for ablation lesion assessment [41].
Guttman et al. [42] have described a technique, whereby an
inversion recovery T1-weighted gradient-echo sequence with
a long inversion time (TI = 700 ms) can be used to visualise
lesion necrosis. This approach allowed the discrimination be-
tween acute ablation lesion and chronic scar in a porcine in-
farct model whilst ablation lesion enhancement was less time-
dependent and more specific compared to LGE. The time
course of lesion visualisation of a T1-weighted inversion re-
covery balanced steady-state free precession (IR-bSSFP) tech-
nique and T2 maps has also been reported with an increase in
lesion volume in T2-derived imaging over a 3-h period whilst
T1-derived lesion volume remained approximately stable
[43]. This approach combining intrinsic contrast–based
methods may provide a means to assess lesion composition
over time. Non-contrast based techniques can also be repeated
multiple times during a procedure and would be potentially
advantageous during a real-time MRI-guided procedure.
MRI can also allow the onlinemonitoring of temperature in
different tissues as the longitudinal and transversal relaxation
time as well as the resonance frequency of water protons are
temperature-dependent [44, 45]. The proton resonance fre-
quency shift (PRF) technique [46] exploits the latter property
to generate information on temperature during a gradient echo
pulse sequence in each pixel of an image (MR-thermometry–
Fig. 6). The thermometry technique can be combined with a
calculation of thermal dose (MR-dosimetry) whereby the in-
tegral of temperature elevation and time is computed to derive
a dose that predicts when destruction of the target tissue is
achieved [44, 47]. When applied in a moving organ such as
in the heart, physiological motion and its associated thermom-
etry artefacts can lead to important errors that need to be
corrected [44, 48, 49•,50–52].
MR-thermometry and dosimetry could potentially allow a
precise means of assessing the efficacy of ablation during real-
time MRI-guided electrophysiology and has been studied in
pre-clinical models. A multi-slice, ECG-triggered, MR-
thermometry pipeline has been used in an ovine model to dem-
onstrate a temperature increase of up to 38° near the catheter tip
during RF ablation [48]. Further, for the assessment of endo-
cardial acute ablation lesions, lesion dimensions on thermal
dose maps derived fromMR-thermometry correlated to dimen-
sions acquired using a T1-weighted gradient echo sequence and
gross pathological examination [49•]. This technique has been
extended to epicardial ablation in a porcine model whereby
lesion dimensions on thermal dose maps within a precision of
1 mm of those measured post-mortem was achieved [32] sim-
ilar to the precision of MR-dosimetry of endocardial ablation
reported by the Bordeaux group [49•]. Several obstacles remain
to be overcome for the thermometry technique including accu-
rate motion estimation due to cardiac and respiratory motion,
intra-scan motion, and inter-scan motion. The presence of
cardiac arrhythmias can also lead to difficulties during image
acquisition which is ECG-triggered. It remains unclear whether
thermal dose achieved during the real-time procedure can pre-
dict the durability of chronic lesions [32].
Real-Time MR-Guided Electrophysiology
for Atrial Arrhythmias
The demonstration of feasibility of real-time MRI-guided
electrophysiology in patients has largely focused on the atri-
um, in part due to ease of access and safety. Diagnostic and
ablation studies have been completed in the right atrium of
pre-clinical models using steerable, non-ferromagnetic MR-
compatible catheters [53, 54] including at 3T [55]. Clinical
translation of the technology has also been achieved in pa-
tients with atrial flutter using passive tracking [24, 56•] and
active catheter tracking [19••, 20••].
Atrial flutter ablation using conventional electrophysiology
systems however has excellent long-term clinical outcomes, a
low risk of complications [57] and is unlikely to be improved
meaningfully by real-time MRI guidance. Typical atrial flutter
is a very well understood arrhythmia with a proven interven-
tional treatment and has been an excellent testing ground in
which to develop clinical workflows and demonstrate feasi-
bility of the technology. There is interest, however, in the
Fig. 6 Real-time assessment of ablation lesions using MR-thermometry
(a) with corresponding temperature profiles (b). (Reproduced with
permission from Mukherjee et al. Europace 2018 Sep 1;20(FI2):f254-
f262. doi: https://doi.org/10.1093/europace/eux341; Creative Commons
user license https://creativecommons.org/licenses/by/4.0/) [32].
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development of catheters and technologies to perform com-
plex arrhythmia ablation inside the MRI scanner including for
atrial fibrillation (AF). Using active tracking, MR-compatible
catheters have been navigated into the left atrium via a trans-
septal puncture to perform left atrial mapping and pulmonary
vein circumferential ablation [58]. A major limitation for real-
time MRI-guided electrophysiology has been the availability
of devices that can be used inside the MRI scanner. Almost all
real-time MRI-guided studies to date have used single bipole
(tip and ring electrode) catheters using point-by-point map-
ping. Recently, the feasibility and safety of a multi-electrode
(10-poles) MR-compatible circular mapping catheter was
evaluated in an ovine model [21•]. A MRI-based cryoablation
system has also been developed and used in canines to per-
form circumferential ablation of the superior vena cava-right
atrial (SVC-RA) junction with no gaps [59•] and in the pul-
monary veins (PVs) with 95% of the PV ostia covered with
scar at 3 months [60]. Availability of MR-compatible trans-
septal puncture kits will also be a pre-requisite for MR-guided
AF ablation. An active MR intra-vascular needle system has
been used in a porcine model to safely puncture the fossa
ovalis via a transfemoral approach whilst allowing direct vi-
sualisation of the needle, atria and surrounding vasculature
[61] but clinical validation of these devices are currently lack-
ing. Further development and investment in these devices
through industrial collaboration are likely to accelerate prog-
ress in the application of real-time MR-guided electrophysiol-
ogy for the treatment of AF.
Another potential application of real-time MRI guidance
could be in patients with congenital heart disease (CHD) re-
quiring catheter ablation for atrial tachycardias. Although in-
terventional MRI for cardiovascular applications was initially
developed in children with CHD to enable cardiac catheter-
isation without the use of fluoroscopy and limit radiation ex-
posure [62], there has been no work on the application of real-
time MRI to guide electrophysiology procedures in these
groups of patients. Arrhythmias are a common cause of mor-
bidity and mortality in these patients, and there may be bene-
fits of accurate anatomical evaluation and substrate assess-
ment with MRI in CHD patients with scar-related atrial tachy-
cardias. Future studies in this cohort are anticipated.
Real-Time MR-Guided Electrophysiology
for Ventricular Arrhythmias
The application of real-time MRI guidance for electrophysiol-
ogy procedures in the ventricle is likely to be the area where
MR-based solutions may have their greatest impact. Catheter
ablation for scar-related ventricular tachycardia (VT) is asso-
ciated with modest success rates and a high rate of complica-
tions including early mortality [63]. The use of real-time MRI
guidance for 3D substrate assessment at the time of procedure,
accurate guidance of catheters to target regions of interest and
utilising real-time techniques to evaluate ablation lesions (e.g.
MR-thermometry) could theoretically improve the efficacy
and safety of VTablation [12]. There are numerous challenges
however prior to the realisation of VTablation under real-time
MRI guidance. The current generation of MR-compatible
catheters may require modif icat ions to improve
manoeuvrability, torque transfer and handling capabilities to
enable mapping and ablation via retrograde, trans-septal and
epicardial access to the LV. The inability to perform defibril-
lation safely inside a MRI scanner represents a major hurdle
and is a pre-requisite for clinical studies in patients. To date,
there are only limited reports of prototype MRI-conditional
defibrillation systems to enable electrical defibrillation both
inside and outside the scanner bore in swine [64•]. Routine
availability of high-fidelity 12-lead ECG systems for use in-
side the MRI scanner is also limited [16] and will be valuable
for diagnostic and monitoring purposes during VT ablation.
The majority of patients who undergo VT ablation have an
implantable cardioverter defibrillator (ICD) in situ [65].
AlthoughMRI has been shown to be safe for imaging patients
with devices, including legacy ICD systems [66], there are
concerns regarding radiofrequency-induced tissue heating
and device failure and their potential impact during long pro-
cedures lasting several hours, as is often the case during VT
ablation. The presence of ICDs also leads to the generation of
artefacts; although wideband LGE sequences have been re-
ported to adequately suppress artefacts and preserve diagnos-
tic image quality for LGE imaging [67, 68], this remains a
challenge for real-time MRI-guided procedures.
Real-time MRI-guided electrophysiology studies have
been performed in animal models of myocardial infarction to
measure EGMs within scar and generate voltage maps in the
LV using both retrograde and trans-septal approaches [69]. In
a separate study, MR-derived borderzone tissue exhibited
more abnormal potentials than dense scar or healthy myocar-
dium in a porcine infarct model using a real-time MRI-guided
system where there was no requirement for registration be-
tween electroanatomical maps and MRI-derived substrate
[22]. Real-time systems have also been used to perform epi-
cardial mapping and ablation in the normal swine left ventricle
[32]. There are no studies to date evaluating real-time MRI-
guided systems in the ventricle of patients with cardiac ar-
rhythmias. Due to the limitations noted above, clinical trans-
lation to VTablation will be difficult to achieve in the next few
years. As an intermediate step, catheter ablation under real-
time MRI guidance in patients with idiopathic premature ven-
tricular contractions (PVCs) may be more feasible. PVC ab-
lation either in the RVor LVoutflow tract with direct assess-
ment of lesion formation using real-time MRI techniques
could lead to further technological developments to realise
the ultimate goal of MRI-guided VT ablation in patients with
ischaemic heart disease.
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Conclusions
There is significant potential for real-time MRI-guided elec-
trophysiology to transform intervention for cardiac arrhyth-
mias but challenges remain. In order for real-timeMRI-guided
procedures to become viable, an increased availability and
range of MR-compatible devices is essential and will require
close collaboration between traditionally distinct clinical
groups (interventional electrophysiology and MR radiology),
academic institutions and industry. Routine adoption of the
technology will only gain momentum with the objective dem-
onstration of clinical benefit for patients at a reasonable cost.
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